These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35369795)

  • 61. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-associated nephropathy and end-stage renal disease in children in the United States.
    Ahuja TS; Abbott KC; Pack L; Kuo YF
    Pediatr Nephrol; 2004 Jul; 19(7):808-11. PubMed ID: 15141343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Will antiretroviral therapy reduce HIV-related liver risk?
    Allen J; Smith C; Bhagani S
    Curr Opin HIV AIDS; 2014 Jan; 9(1):48-53. PubMed ID: 24247670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinicopathological correlation of kidney disease in HIV infection pre- and post-ART rollout.
    Diana NE; Davies M; Mosiane P; Vermeulen A; Naicker S
    PLoS One; 2022; 17(5):e0269260. PubMed ID: 35639767
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predicted coreceptor usage at end-stage HIV disease in tissues derived from subjects on antiretroviral therapy with an undetectable plasma viral load.
    Lamers SL; Fogel GB; Liu ES; Nolan DJ; Salemi M; Barbier AE; Rose R; Singer EJ; McGrath MS
    Infect Genet Evol; 2017 Jul; 51():194-197. PubMed ID: 28392467
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV].
    Gozdowska J; Durlik M
    Przegl Lek; 2008; 65(2):82-6. PubMed ID: 18663906
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changing concepts of HIV infection and renal disease.
    Hou J; Nast CC
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):144-152. PubMed ID: 29337702
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human immunodeficiency virus-associated nephropathy.
    Lai CF; Huang JW; Lin WC; Hung CC; Chu TS
    J Formos Med Assoc; 2006 Aug; 105(8):680-4. PubMed ID: 16935771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management.
    Atta MG; Lucas GM; Fine DM
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):365-71. PubMed ID: 18588500
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study.
    Franke MF; Robins JM; Mugabo J; Kaigamba F; Cain LE; Fleming JG; Murray MB
    PLoS Med; 2011 May; 8(5):e1001029. PubMed ID: 21559327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quadruple versus triple combination antiretroviral therapies for treatment naive people with HIV: systematic review and meta-analysis of randomised controlled trials.
    Feng Q; Zhou A; Zou H; Ingle S; May MT; Cai W; Cheng CY; Yang Z; Tang J
    BMJ; 2019 Jul; 366():l4179. PubMed ID: 31285198
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis.
    Llewellyn A; Simmonds M; Irving WL; Brunton G; Sowden AJ
    Hepatol Med Policy; 2016; 1():10. PubMed ID: 30288314
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.
    Carroll V; Garzino-Demo A
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26121984
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Renal transplantation between HIV-positive donors and recipients justified.
    Muller E; Barday Z; Mendelson M; Kahn D
    S Afr Med J; 2012 Mar; 102(6):497-8. PubMed ID: 22668948
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Systematic Review Exploring the Range of Renal Complications of Human Immunodeficiency Virus.
    Yussuf FM; Barbarawi A; Nor MA; Ali AI; Sheikh IM; Ogedegbe OJ; Tabowei G; Jimoh A; Ozokolie GE; Igbinomwanhia O
    Cureus; 2023 Mar; 15(3):e36755. PubMed ID: 37123789
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnosis and natural history of HIV-associated nephropathy.
    Atta MG
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):52-8. PubMed ID: 20005489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Outcome and prognostic factors in HIV-1-infected patients on dialysis in the cART era: a GESIDA/SEN cohort study.
    Trullàs JC; Cofan F; Barril G; Martínez-Castelao A; Jofre R; Rivera M; Martínez-Ara J; Ros S; Perez I; Moreno A; Miró JM;
    J Acquir Immune Defic Syndr; 2011 Aug; 57(4):276-83. PubMed ID: 21623213
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study.
    Dragovic G; Smith CJ; Jevtovic D; Dimitrijevic B; Kusic J; Youle M; Johnson MA
    BMC Infect Dis; 2016 Mar; 16():106. PubMed ID: 26939611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.